Cargando…
Innovative therapies for malignant brain tumors: the road to a tailored cure
BACKGROUND: Immune tolerance, immune escape, neoangiogenesis, phenotypic changes, and glioma stem cells are all responsible for the resistance of malignant brain tumors to current therapies and persistent recurrence. The present study provides a panoramic view of innovative therapies for malignant b...
Autores principales: | Giotta Lucifero, Alice, Luzzi, Sabino, Brambilla, Ilaria, Trabatti, Chiara, Mosconi, Mario, Savasta, Salvatore, Foiadelli, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975829/ https://www.ncbi.nlm.nih.gov/pubmed/32608372 http://dx.doi.org/10.23750/abm.v91i7-S.9951 |
Ejemplares similares
-
The impact of stem cells in neuro-oncology: applications, evidence, limitations and challenges
por: Luzzi, Sabino, et al.
Publicado: (2020) -
Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
Gene therapies for high-grade gliomas: from the bench to the bedside
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges
por: Luzzi, Sabino, et al.
Publicado: (2020) -
Targeting the medulloblastoma: a molecular-based approach
por: Luzzi, Sabino, et al.
Publicado: (2020)